Novo Nordisk A/S
F:NOVC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novo Nordisk A/S
F:NOVC
|
DK |
|
Marathon Petroleum Corp
NYSE:MPC
|
US |
|
D
|
Delecta Ltd
ASX:DLC
|
AU |
|
Aero Energy Ltd
F:J5B
|
CA |
|
Avolta AG
SIX:AVOL
|
CH |
|
M
|
Minth Group Ltd
HKEX:425
|
CN |
|
Threat Protect Australia Ltd
ASX:TPS
|
AU |
|
Sergeferrari Group SA
PAR:SEFER
|
FR |
|
A
|
Axis Bank Ltd
BSE:532215
|
IN |
|
Swisscom AG
SIX:SCMN
|
CH |
|
V
|
Viking Holdings Ltd
NYSE:VIK
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOVC's stock price target?
Not Available
NOVC does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Novo Nordisk A/S?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novo Nordisk A/S?
Projected CAGR
-3%
Over the last 14 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 8 years is -3%.
What is the Net Income forecast for Novo Nordisk A/S?
Projected CAGR
-1%
Over the last 14 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 8 years is -1%.
